Senior figures from GlaxoSmithKline, Roche, Bayer, and Johnson & Johnson have been named to an 18-strong executive council for health at DigitalEurope – a trade association representing
Every patient, every doctor or nurse, every hospital worker is a human being influenced by their experiences outside of healthcare. In the consumer world, we have all come to expect speed and inter
In the year since the UK went into its first lockdown to limit the spread of COVID-19 the country’s health service has undergone an unprecedented digital transformation.
The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape - and one of the key ones is digital transformation
Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, any definitive ‘coming of age’ moment for the sector was unlikely.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh